Prothena Management
Management criteria checks 2/4
Prothena's CEO is Gene Kinney, appointed in Sep 2016, has a tenure of 7.58 years. total yearly compensation is $7.04M, comprised of 9% salary and 91% bonuses, including company stock and options. directly owns 0.024% of the company’s shares, worth $262.98K. The average tenure of the management team and the board of directors is 7.1 years and 7.6 years respectively.
Key information
Gene Kinney
Chief executive officer
US$7.0m
Total compensation
CEO salary percentage | 9.0% |
CEO tenure | 7.6yrs |
CEO ownership | 0.02% |
Management average tenure | 7.1yrs |
Board average tenure | 7.6yrs |
Recent management updates
Recent updates
Prothena: Alzheimer's Data Update In 2024 Could Move The Needle
Feb 23Investors Don't See Light At End Of Prothena Corporation plc's (NASDAQ:PRTA) Tunnel And Push Stock Down 33%
Feb 08Are Investors Undervaluing Prothena Corporation plc (NASDAQ:PRTA) By 32%?
Dec 20Prothena (NASDAQ:PRTA) Is In A Strong Position To Grow Its Business
Nov 24Prothena Corporation plc's (NASDAQ:PRTA) 29% Share Price Plunge Could Signal Some Risk
Oct 27Companies Like Prothena (NASDAQ:PRTA) Are In A Position To Invest In Growth
Aug 25What You Need To Know About The Prothena Corporation plc (NASDAQ:PRTA) Analyst Downgrade Today
May 10We Think Prothena (NASDAQ:PRTA) Can Easily Afford To Drive Business Growth
Apr 23Time To Worry? Analysts Just Downgraded Their Prothena Corporation plc (NASDAQ:PRTA) Outlook
Mar 01We're Not Very Worried About Prothena's (NASDAQ:PRTA) Cash Burn Rate
Dec 28Prothena: Paying A Premium To Cover All The Alzheimer's Bases
Sep 29Prothena GAAP EPS of -$0.88 misses by $0.31
Aug 08Bearish: Analysts Just Cut Their Prothena Corporation plc (NASDAQ:PRTA) Revenue and EPS estimates
May 08Are Prothena Corporation plc (NASDAQ:PRTA) Investors Paying Above The Intrinsic Value?
Jan 10Prothena: A Biotech Company With A Promising Pipeline
Dec 01CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | US$7m | US$631k | -US$147m |
Sep 30 2023 | n/a | n/a | -US$73m |
Jun 30 2023 | n/a | n/a | -US$141m |
Mar 31 2023 | n/a | n/a | -US$128m |
Dec 31 2022 | US$7m | US$601k | -US$117m |
Sep 30 2022 | n/a | n/a | -US$156m |
Jun 30 2022 | n/a | n/a | -US$1m |
Mar 31 2022 | n/a | n/a | US$67m |
Dec 31 2021 | US$5m | US$573k | US$67m |
Sep 30 2021 | n/a | n/a | US$69m |
Jun 30 2021 | n/a | n/a | -US$70m |
Mar 31 2021 | n/a | n/a | -US$124m |
Dec 31 2020 | US$3m | US$554k | -US$111m |
Sep 30 2020 | n/a | n/a | -US$102m |
Jun 30 2020 | n/a | n/a | -US$91m |
Mar 31 2020 | n/a | n/a | -US$80m |
Dec 31 2019 | US$3m | US$538k | -US$78m |
Sep 30 2019 | n/a | n/a | -US$79m |
Jun 30 2019 | n/a | n/a | -US$84m |
Mar 31 2019 | n/a | n/a | -US$128m |
Dec 31 2018 | US$11m | US$525k | -US$156m |
Sep 30 2018 | n/a | n/a | -US$181m |
Jun 30 2018 | n/a | n/a | -US$209m |
Mar 31 2018 | n/a | n/a | -US$167m |
Dec 31 2017 | US$5m | US$521k | -US$153m |
Compensation vs Market: Gene's total compensation ($USD7.04M) is above average for companies of similar size in the US market ($USD3.47M).
Compensation vs Earnings: Gene's compensation has increased whilst the company is unprofitable.
CEO
Gene Kinney (54 yo)
7.6yrs
Tenure
US$7,043,826
Compensation
Dr. Gene G. Kinney, Ph D., has been the Chief Executive Officer and President of Prothena Corporation plc since September 26, 2016 and October 3, 2016 respectively and served as its Chief Operating Officer...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 7.6yrs | US$7.04m | 0.024% $ 263.0k | |
CFO & Chief Strategy Officer | 11.1yrs | US$2.70m | 0.0060% $ 65.8k | |
Chief Operating Officer | 2.5yrs | US$2.63m | 0% $ 0 | |
Chief Regulatory Officer | 7.3yrs | US$2.57m | 0% $ 0 | |
Chief Medical Officer | 3yrs | US$2.68m | 0% $ 0 | |
Chief Accounting Officer & Controller | 10.9yrs | no data | no data | |
Chief Scientific Officer | 6.8yrs | US$3.34m | no data | |
Vice President of Investor Relations | no data | no data | no data | |
Chief Legal Officer | no data | US$1.18m | no data | |
Chief People Officer | less than a year | no data | no data | |
Company Secretary | no data | no data | no data |
7.1yrs
Average Tenure
54yo
Average Age
Experienced Management: PRTA's management team is seasoned and experienced (7.1 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 7.6yrs | US$7.04m | 0.024% $ 263.0k | |
Independent Director | 1.7yrs | US$896.63k | 0% $ 0 | |
Independent Director | 11.3yrs | US$912.48k | 0.0023% $ 25.1k | |
Independent Director | less than a year | no data | no data | |
Independent Chairman | 18.9yrs | US$923.48k | 0.00045% $ 5.0k | |
Independent Director | 11.3yrs | US$354.39k | 0% $ 0 | |
Independent Director | 10.8yrs | US$901.73k | 0.0078% $ 86.5k | |
Independent Director | 9.3yrs | US$907.48k | 0% $ 0 | |
Independent Director | 4.8yrs | US$908.48k | 0% $ 0 | |
Independent Director | 4.3yrs | no data | no data | |
Independent Director | less than a year | US$1.70m | no data |
7.6yrs
Average Tenure
63yo
Average Age
Experienced Board: PRTA's board of directors are considered experienced (7.6 years average tenure).